HIBH is building Nepal's first pharmaceutical-grade molecular extraction facility in Solukhumbu — converting high-altitude medicinal plants into global biotech value, while training the next generation of Nepali scientists.
That 35–60× value gap is what HIBH exists to close — through science, community, and technology.
High-purity Berberine HCl (≥95% HPLC) and standardized Chiraito extract for global pharmaceutical and nutraceutical markets. Nepal-grown. Science-validated.
Invasive Michāhā weeds and forest debris converted into biomass pellets. Processing residues become organic compost. Zero-waste by design.
Digital MRV system tracking carbon sequestration in real-time. dMRV-verified credits tradeable in voluntary carbon markets. Asset-light, high-margin.
SHIBH is actively engaging with institutional partners, investors, and research organisations worldwide.
We are in active discussions with development finance institutions, research organisations, and innovation partners. Announcements will be made as partnerships are formalised.
We are seeking institutional partners, investors, and knowledge collaborators to help build Nepal's bio-economy.